ATE225771T1 - Prostaglandin-pharmazeutische-zusammensetzungen - Google Patents

Prostaglandin-pharmazeutische-zusammensetzungen

Info

Publication number
ATE225771T1
ATE225771T1 AT98934967T AT98934967T ATE225771T1 AT E225771 T1 ATE225771 T1 AT E225771T1 AT 98934967 T AT98934967 T AT 98934967T AT 98934967 T AT98934967 T AT 98934967T AT E225771 T1 ATE225771 T1 AT E225771T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
prostaglandin
prostaglandin pharmaceutical
compounds
general formula
Prior art date
Application number
AT98934967T
Other languages
English (en)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of ATE225771T1 publication Critical patent/ATE225771T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT98934967T 1997-06-19 1998-06-17 Prostaglandin-pharmazeutische-zusammensetzungen ATE225771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001440A IT1292377B1 (it) 1997-06-19 1997-06-19 Composizioni farmaceutiche a base di prostaglandine
PCT/EP1998/003645 WO1998058910A1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE225771T1 true ATE225771T1 (de) 2002-10-15

Family

ID=11377397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934967T ATE225771T1 (de) 1997-06-19 1998-06-17 Prostaglandin-pharmazeutische-zusammensetzungen

Country Status (19)

Country Link
US (1) US6211233B1 (de)
EP (1) EP0989972B1 (de)
JP (1) JP4394170B2 (de)
KR (1) KR20010013625A (de)
CN (1) CN1260778A (de)
AT (1) ATE225771T1 (de)
AU (1) AU740683B2 (de)
BR (1) BR9810163B1 (de)
CA (1) CA2292836C (de)
DE (1) DE69808619T2 (de)
DK (1) DK0989972T3 (de)
ES (1) ES2185188T3 (de)
HU (1) HUP0004071A3 (de)
IL (1) IL132690A (de)
IT (1) IT1292377B1 (de)
PT (1) PT989972E (de)
RU (1) RU2000100807A (de)
SI (1) SI0989972T1 (de)
WO (1) WO1998058910A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
WO2000051978A1 (en) 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
WO2002060387A2 (en) * 2001-01-30 2002-08-08 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
AU2003208525B9 (en) * 2002-02-04 2009-08-27 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
EP3002277B1 (de) * 2004-01-05 2019-11-06 Nicox S.A. Prostaglandinderivate
CA2613748A1 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
CA2613010A1 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Fluoroprostaglandins nitroderivatives
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2007126609A1 (en) 2006-03-29 2007-11-08 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US8041859B2 (en) * 2007-11-05 2011-10-18 Honywell International Inc. Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
EP2699242B1 (de) 2011-04-19 2017-11-01 Alfama, Inc. Kohlenmonoxidfreisetzende moleküle und ihre verwendungen
EP2734235B1 (de) 2011-07-21 2017-03-22 Alfama, Inc. Kohlenmonoxidfreisetzende rutheniummoleküle und ihre verwendungen
CA2897571C (en) 2013-01-21 2018-12-18 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371199D1 (en) * 1982-08-24 1987-06-04 Teijin Ltd Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
DK0759899T3 (da) * 1994-05-10 1999-12-20 Nicox Sa Nitroforbindelser og sammensætninger deraf med antiinflammatoriske, analgetiske og antitrombotiske aktiviteter
US5625083A (en) 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

Also Published As

Publication number Publication date
ES2185188T3 (es) 2003-04-16
BR9810163A (pt) 2000-08-08
DE69808619D1 (de) 2002-11-14
HUP0004071A2 (hu) 2001-04-28
EP0989972B1 (de) 2002-10-09
DK0989972T3 (da) 2003-02-10
CN1260778A (zh) 2000-07-19
EP0989972A1 (de) 2000-04-05
PT989972E (pt) 2003-02-28
AU8438698A (en) 1999-01-04
HUP0004071A3 (en) 2002-12-28
DE69808619T2 (de) 2003-06-12
US6211233B1 (en) 2001-04-03
AU740683B2 (en) 2001-11-08
JP2002506440A (ja) 2002-02-26
WO1998058910A1 (en) 1998-12-30
BR9810163B1 (pt) 2009-01-13
CA2292836C (en) 2010-03-02
CA2292836A1 (en) 1998-12-30
IL132690A (en) 2004-06-01
ITMI971440A1 (it) 1998-12-19
RU2000100807A (ru) 2002-02-27
IT1292377B1 (it) 1999-02-08
IL132690A0 (en) 2001-03-19
SI0989972T1 (en) 2003-04-30
ITMI971440A0 (de) 1997-06-19
KR20010013625A (ko) 2001-02-26
JP4394170B2 (ja) 2010-01-06

Similar Documents

Publication Publication Date Title
ATE225771T1 (de) Prostaglandin-pharmazeutische-zusammensetzungen
ATE306261T1 (de) Antithrombosemittel
PT1193270E (pt) Pirrolobenzodiazepinas
DE69830504D1 (de) Antithrombotische mitteln
DK0941218T3 (da) Antithrombotiske organiske nitrater
HN1998000036A (es) Compuesto de pirazina
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
BG103485A (en) Ketobanzamides as calpain inhibitors
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
SE9901077D0 (sv) Novel use
ATE235462T1 (de) Metalloproteinase-inhibitoren
HN1998000045A (es) Composiciones farmaceuticas
HN1998000102A (es) Composiciones solubilizadas de sertralina
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
GT199900160A (es) Compuestos plaguicidas de bis-oxima.
AR005042A1 (es) Procedimiento para la preparacion de un antagonista endotelin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0989972

Country of ref document: EP